Ranbaxy Set To launch Aricept Generic In U.S. As FDA OKs Ohm Labs Data; Will Lipitor Be Next ?

MUMBAI - India's largest drug maker Ranbaxy - now part of Japanese pharma Daiichi Sankyo - is set to launch a generic version of the blockbuster Alzheimer's disease drug Aricept (donepezil) in the U.S. market, leading experts to predict that Ranbaxy may also be on track to launch a generic of the world's best selling drug, Lipitor (atorvastatin)